A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugsElena Crisà, Dario Ferrero, Ermanno Venturino et al.|Annals of Hematology|2010Cited by 60
Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor‐experienced patients with paroxysmal nocturnal hemoglobinuriaPhillip Scheinberg, Austin Kulasekararaj, Cristina Barrenetxea Lekue et al.|American Journal of Hematology|2024Cited by 42
Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agentsDario Ferrero, Mario Boccadoro, Elena Crisà et al.|Annals of Hematology|2014Cited by 31
Combining the HCT-CI, G8, and AML-Score for Fitness Evaluation of Elderly Patients with Acute Myeloid Leukemia: A Single Center AnalysisSemra Aydin, Alessandro Busca, Roberto Passera et al.|Cancers|2023Cited by 12
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: Evidence for premature aging of the myeloid compartmentChiara Lobetti‐Bodoni, Marco Ladetto, Dario Ferrero et al.|Mechanisms of Ageing and Development|2012Cited by 9